Emicizumab
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 836 publications
Emicizumab in Acquired Haemophilia A: A Single Haemophilia Comprehensive Care Centre Experience in the United Kingdom.
Journal: Seminars in thrombosis and hemostasis
Published: April 14, 2026
Non-clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B.
Journal: The Cochrane database of systematic reviews
Published: March 24, 2026
Bleeding rates, healthcare utilization, and costs among patients with hemophilia a without inhibitors treated with concomitant octocog alfa or extended half-life factor VIII while on emicizumab prophylaxis.
Journal: Journal of medical economics
Published: March 13, 2026
Comparative Efficacy and Safety of Non-Clotting Factor Prophylaxis Versus. on-Demand Therapy in Hemophilia: A Meta-Analysis of Randomized Controlled Trials.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: March 03, 2026
Factor-VIII mimetic bispecific antibodies for the treatment of hemophilia A: an update.
Journal: Expert review of clinical pharmacology
Published: February 23, 2026
Gene therapy in the treatment of hemophilia A: a systematic review and meta-analysis.
Journal: Expert review of hematology
Published: February 19, 2026
Real-world adherence to and persistence with emicizumab in people with hemophilia A using a national claims database.
Journal: Journal of managed care & specialty pharmacy
Published: February 04, 2026
Pharmacodynamic Interaction Between Emicizumab and Coagulation Factor VIII.
Journal: Thrombosis and haemostasis
Published: February 03, 2026
COVID-19-Associated Acquired Hemophilia A With an Exceptionally High Inhibitor Titer: A Case of Remission and Overwhelming Sepsis.
Journal: Cureus
Published: January 29, 2026
Acquired Hemophilia A After Neoadjuvant Immunotherapy for Renal Cell Carcinoma.
Journal: Rhode Island medical journal (2013)
Published: January 27, 2026
Emicizumab prophylaxis beyond clinical trials: a multicenter, prospective real-world study of pediatric hemophilia patients with and without inhibitors.
Journal: European journal of pediatrics
Published: January 25, 2026
Redefining hemophilia management: treatment goals, nonfactor replacement therapies, and the role of fitusiran.
Journal: The American journal of managed care
Published: January 21, 2026
Last Updated: 04/28/2026